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ABSTRACT
Koi Herpesvirus (KHV) is a malignant virus infecting the goldfish and koi in all stadia and cause mortality up
to 95%. The purpose of this study was to determine the potency and efficacy of inactivated-vaccine in
addition with adjuvant against KHV in koi fish. The viral propagation was done using a KF-1 cell line in 25
cm2 flask. The cultured virus was harvested on 12 days post inoculation, and then the harvested virus was
inactivated with 0.1% formalin as inactivated-vaccine. Three hundred of test fish (10.38 ± 1.25 g) maintained
in 126 L of plastic containers with aeration, and fed with pellets twice a day. After 14 days of adaptation, the
fish were divided into five treatments (A= vaccine; B= vaccine + Complete Freund’s Adjuvant; C= vaccine +
Incomplete Freund’s Adjuvant; K+= positive control, and K-= negative control) and each treatment has four
replicates. Vaccine was given by injecting intramuscularly of 0.1 mL per fish. All fish were challenged by
injecting intramuscularly of 0.1 mL of KHV virus with concentration of 104.58 TCID50/mL after 21 days post
vaccination. The results showed that the B treatment had higher (P<0.05) values of hematocrit level,
lysozyme activity, and titer of antibody compared with positive control. In addition, the survival of fish in
B treatment also had the highest percentages and significantly different compared to other treatments
(P<0.05). The conclusion of this research was the application of inactivated KHV vaccine in 0.1% formalin
with the addition of Complete Freund’s Adjuvant through the injection dose 0.1 mL fish-1 in 104.58 TCID50/mL
capable to enhance the immune responses and raised the optimal protection of KHV antibody in koi fish.
KEYWORDS: inactivated vaccines; adjuvants; immune responses; Cyprinus carpio; KHV
INTRODUCTION
Koi Herpesvirus Disease (KHV/KHVD) is a virus that
causes the contagious disease in koi and goldfish
(Ilouze et al., 2006). KHVD was first reported in Israel
and the United States in 1998. Furthermore, the
disease spread to other countries such as Poland, UK,
Germany, and the Netherlands (Antychowicz et al.,
2005). In Asia, KHVD outbreak was first reported in
Indonesia in April 2002 (Melba, 2004).
Fish infected with KHV showed pale white and
necrosis in the gill filaments. Other clinical symptoms
may include abnormal eye, pale body surface, mucus
production, and pale spots on the skin. KHV outbreaks
in some cases showed no clinical symptoms (Lio-Po,
2011). This virus can infect goldfish when the water
temperature ranging from 17°C-27°C whereas high
virulence occurs at a temperature of 22°C-24°C
(Perelberg et al., 2003). Deaths caused by KHV may
reach 80%-95% (Sunarto et al., 2005).
Several kinds of vaccines used in fish farming,
among others; whole-cell vaccines, vaccines from cell
components, and DNA vaccines. The viral vaccine is
an antigen preparation derived from attenuated or
killed. Yasumoto et al. (2006) in Japan developed a
formalin-inactivated vaccine KHV by utilizing lipo-
somal membrane applied to the fish feed.
Nakajima et al. (1999) using iridovirus vaccine from
GF cell (grunt fin) on red sea bream (Pagrus major)
which was formalin inactivated for 12 days at 4°C and
obtain 72% of relative percent survival (RPS). The type
of adjuvant used is Complete Freund’s Adjuvant (CFA)
and Incomplete Freund’s Adjuvant (IFA). According to
Aucouturier et al. (2001), IFA is a water in oil (W/O)
emulsion, which is able to improve and stabilize the
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antibody titer. The purpose of this study was to de-
termine the potency and efficacy of inactivated
vaccine against KHV combine with adjuvant which
produced from KF-1 cell cultures.
MATERIALS AND METHODS
Procurement Fish and Virus Isolates
Three hundred of koi fish (Cyprinus carpio) used
in this study (average weight of 10.38 ± 1.25 g) were
obtained from  a private farm in Sukabumi, West Java
which provides the SPF (Specific Pathogen Free) KHV
through previous PCR test. Virus strain was namely
BJMN-2, which was a collection of Research Station
for Fish Disease Control, Depok, Indonesia.
Cell Culture and KHV Virus
KF-1 cells were used in this study. KF-1 cells were
grown in T-flasks at 25°C to confluence in Leibovitz’s
media (L-15 : Gibco)  supplemented with 20% FBS (Fe-
tal Bovine Serum : Gibco). The monolayers of KF-1
cells were inoculated with KHV inoculum then supple-
mented with 2% FBS, respectively. Infected cells were
incubated at 25°C. Cytopathic effect (CPE) was daily
observed under a light microscopy.
The viral cultured was harvested when cytopathic
effect (CPE) had reached ± 80%. Supernatant was taken
and stored at -80°C until ready to use and mostly
used for the measurement of TCID
50
.
TCID
50
Determination of tissue culture infective dose
(TCID
50
) was performed to quantify how much infec-
tious virus was in a vaccine preparation. TCID
50
 cal-
culation was based on the method of Reed & Muench
(1938):
Where: a= % positive at dilution below 50%
b= % positive at dilution above 50%
Production of Vaccines
The harvested virus was inactivated refers to
Yasumoto et al. (2006) with minor modifications.
Unlike what did Yasumoto in common carp (Cyprinus
carpio) where the KHV vaccines produced from KF-1
cell is inactivated with 0.3% formalin and stored for
48 hours at a temperature of 24°C before use.
The vaccine in this study are inactivated with for-
malin 0.1% of the KHV virus then filtered using a 450
nm millipore and directly used for the test.
Adjuvants was substances added to vaccines to
stimulate the immune response. Differences between
CFA and IFA contained in the composition of the
constituent material which was in 1 mL CFA consisted
of 1 mg of Mycobacterium tuberculosis in the form of
heat-killed/dried; 0.85 mL of paraffin oil; and 0.15 mL
mannide monooleate. However M. tuberculosis not con-
tained in the IFA.
The comparison between either complete or in-
complete adjuvant and vaccine solution were 0.25/
0.75 (v/v). The composition of adjuvant and vaccine
was obtained from Agar Gel  Precipitation Test (AGPT)
which carried out previously.
Vaccination
Vaccination was performed by the method of in-
tramuscularly injection with a volume of 0.1 mL/fish.
The experimental design was Completely Random-
ized Design with five treatments and four replica-
tions as follows: treatment A: vaccines; treatment B:
vaccine + Complete Freund’s Adjuvant; treatment C:
vaccine + Incomplete Freund’s Adjuvant; K+: positive
control (injected with PBS, tested challenged); K-:
negative control (injected with PBS, challenged not
tested).
Fish were reared in plastic container sized 60 cm
x 70 cm x 40 cm with stocking density of 15 fish
container-1. Water temperature was range at 24°C-
25°C and fed with a pellet twice a day at satiation. The
fourth replications in each treatment used for blood
and serum sampling.
Challenge Test
Challenge test was performed on day 21 after
vaccination and maintenance carried out for 14 days
post challenge test. The fish were injected intramus-
cularly with 0.1 mL of virus inucula/fish. Virus was
diluted up to 100 times (10-2) of TCID
50
/mL have been
done previously. TCID
50
 already used to obtain Lethal
Dose 50 (LD
50
) from the Koch’s postulates. Koch
postulate test was done with serial dilutions using
TCID
50
 dose without dilution, TCID
50
 dilution 10 times,
TCID
50
 dilution 100 times, TCID
50
 dilution 1,000 times
and TCID
50
 dilution 10,000 times. Koch’s postulates
test showed that the LD
50
 was obtained on TCID
50
dilution 100 times. Dose of 100 times of virus dilu-
tion then was used for a challenge test by injecting
0.1 mL each fish.
Measurement of Immunological Parameters
Measurement parameters of the immunological
system consists of antibody titer by ELISA,
hematocrit, and lysozyme activity.









ab
a50%
TCID50
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Preparation of antigen for the ELISA test con-
ducted prior to the KHV virus purification process
according to Ronen et al. (2003). Purified protein of
KHV antigen was measured by the method of Bradford.
Antigen was coated 10 ug/mL in each well and incu-
bated at 4°C overnight. Directly plate was blocked
using 200 µL of PBS-BSA 1% and incubated at 22°C for
one hour. Plate was washed three times with 400 µL
of PBS-T. Serum samples were then added to each
well of 200 µL (Duplo) and incubated at a tempera-
ture of 22°C for three hours. Plate was washed three
times with 400 µL of PBS-T. Koi carp (Cyprinus carpio)
IgM monoclonal antibody (AQUATIC Diagnostics Ltd.)
added about 100 µL in each well and incubated at
22°C for one hour. Plate was washed three times with
400 µL of PBS-T. Anti-mouse IgG-peroxidase antibody
produced in rabbit (SIGMA-ALDRICH) was added to
each well of 100 µL and incubated at 22°C for one
hour. Plate was washed three times with 400 µL of
PBS-T. One-Step Ultra TMB-ELISA was further added
to each well of 100 µL and let stand for 10 minutes.
The reaction was stopped by adding 50 µL H
2
SO
4
2M
and do the reading optical density (OD) at 450 nm.
The cut of value (CV) in this test was obtained by the
equation:
CV = Mean negative control + (2 x standard
deviation)
Hematocrit measurement is done by comparing a
part of blood that settles (a) to all parts of the blood
contained in the microhematocrit tube (b), hema-
tocrit levels expressed as % volume solid blood cells
were calculated by using the equation of:
Measurement of lysozyme was conducted accord-
ing the method of Kafilzadeh (2013) which 10 µL of
plasma added into 190 µL liquid suspension of Micro-
coccus lysodeicticus (Sigma) at 25°C. The lysozyme ac-
tivity can be formulated as follows:
Lysozyme activity (UI/mL/minute)= [(OD 30s –
OD 30m) x 1,000] x (1/(t x p))
where: 1,000 was conversion of the absorbance
(OD) into international units (UI),
t was time (minute), p was plasma volume (mL), OD
30s is optical density readings on 30 seconds, OD
30m is optical density readings on 30 minutes
Survival Rate (SR)
where: Nt was the number of live koi at the end of the
observation, No was the number of koi in the initial
observation
Relative Percent Survival (RPS)
Statistical Analysis
Results are presented as Means ± SD (standard
deviation of means) and homogenic data was per-
form before analysis. The SPSS (Version, 20.0) pro-
grams were used for the statistical analyses. One-
way analysis of variance (One-way ANOVA) was used
to determine whether there were any significant
differences between treatments. If so, all treatments
were further tested by Duncan Multiple Range Test
(DMRT). All test were performed at the 95% confi-
dence interval (P  0.05)
RESULTS AND DISCUSSIONS
Survival Rate
Survival of fish among treatments were signifi-
cantly different (P<0.05). All fish in K- treatment (nega-
tive control) survived until the end of the study. This
was in contrast with the treatment of K+ (positive
control) where at the end of the study fish alive only
15.55%. Fish in treatment A (vaccine), B (vaccine +
CFA), and C (vaccine + IFA) successively survival of
68.88%, 82.22%, and 60.00%. The highest survival was
achieved by treatment B. Value of survival and rela-
tive survival were shown in Table 1.
Relative Percent Survival
While relative survival of both treatment A and C
are not significantly different, but A and C signifi-
cantly different with B (P<0.05). The highest relative
survival was achieved by treatment B, its the same
thing with the achievements of the percentage of
survival.
The survival of control fish were significantly
different (P<0.05) compared with other treatments
(Table 1). It indicates that vaccination improved sur-
vival of fish. All fish in the negative control alive from
the beginning to the end of the study, and unlike the
case with the positive control, in which the
remaining fish was only 15.55 ± 3.84%. The highest
survival was achieved by treatment vaccination with
the addition of Complete Freund’s Adjuvant/CFA (treat-
ment B), followed by vaccine treatment (treatment
A) and then treated with additional vaccinations In-
100% x 
b
a
He 
100% x 
No
Nt
(%) SR 
100 x 
control  of  mortality  Fish %
vaccinated  of  mortality  fish %
1RPS 






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complete Freund’s Adjuvant / IFA (treatment C). The
addition of the adjuvant vaccine was found to further
increase the survival of fish than just vaccine only. It
is shown that B was significantly different (P<0.05)
with A and in accordance with the opinion of Kuby
(2007), that the adjuvant is a substance when mixed
with antigen then injected together will work to
improve the immunogenicity of the antigen.
While the effectiveness of the vaccine protection
can also be seen from the relative survival in Table 1.
The highest survival was achieved by treatment B
followed treatment A and C. The treatments A was
significantly different (P<0.05) with C. RPS were
obtained in the treatment of vaccination meet the
range for effective protection in the process of
vaccination unless treatment C (52.63 ± 7.89%). This
is in line with Amend (1981) that for effective pro-
tection RPS suggested value of more than 60%. Based
on the results of this study it is not advisable to use
C treatment because C does not meet the minimum
limit the effectiveness of vaccine protection.
ELISA Assay
Vaccination aims to induce long-term immunity
by stimulating specific components of the immune
response is an antibody by inducing the formation of
specific antibody. Figure 1 shows absorbance of
vaccinated koi higher than the control. Before vacci-
nation antibody titers tend to be similar and not sig-
nificantly different (P>0.05) among treatments. The
Table 1. Survival rate (SR) and relative percent survival (RPS) of fish during the study
period of adjuvant and formalin inactivated vaccine against KHV in koi
K+ K- A B C
SR (%) 15.55 ± 3.84a 100.00 ± 0.00e 68.88 ± 3.84c 82.22 ± 3.84d 60.00 ± 6.66b
RPS (%) 0a 100 ± 0.00e 63.15 ± 4.53c 78.94 ± 4.55d 52.63 ± 7.89e
Treatments
Parameter
Figure 1. ELISA absorbances during the study period of adjuvant and formalin inacti-
vated vaccine against KHV in koi. This test had been carried out using a
monoclonal antibody. Description: no vaccined, challanged (K+), no vaccined,
no challanged (K-), vaccines (A), Complete Freund’s Adjuvant vaccined (B),
Incomplete Freund’s Adjuvant vaccined (C), cut off value (CV), vaccination (V),
challenge test (T)
Description: no vaccined, + challanged (K+), no vaccined,+ no challanged (K-), KHV vaccines (A), KHV vaccine
with the addition of Complete Freund’s Adjuvant (B), KHV vaccine with the addition of Incomplete
Freund’s Adjuvant (C). Different superscript in the same row indicate significantly different (P<0.05).
Data is expressed as Mean ± SD
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cut off value (CV) or borderline positive value indi-
cates the formation of protective antibodies against
KHV obtained in this study at 0.377 nm. Absorbance
values of K+ and K- during the study were below the
CV, indicates that no protective antibodies against
KHV.
Positive anti-KHV antibodies formed in all treat-
ments vaccination from 14 to 35 dpv. Anti-KHV anti-
bodies begin to form at 7 dpv namely in treatment A
and C as indicated by intersect to the line CV
(Figure 1). While on treatment B had positive anti-
bodies directly even reach the top of the formation
of antibodies. This is presumably due to the effect of
the vaccine and the addition of adjuvants in vaccines.
Antibody formation is influenced by several factors
such as temperature, dose of the vaccine, vaccine
administration, the age, and weight of fish as well as
the nature of the antigen (Ellis, 1988). The use of
adjuvants capable of increasing the titer two times
higher than without adjuvant (De Jong et al., 2003).
In addition, adjuvants are also able to create a
balance of humoral antibody response (Hunter, 2002).
It shows that the inserted antigen be antigenic as
capable of inducing an immune response to an in-
crease in the value of antibody titers at vaccination
treatment.
Hematocrit Level
Hematocrit level can be seen in Figure 2. Prior to
vaccination and one week after vaccination there was
no significant difference among treatments (P>0.05).
At 14 dpv, there are significant differences (P<0.05)
between K+, K-, C with A and B. The highest hema-
tocrit levels achieved on day 21 dpv in treatment B
and significantly different (P<0.05) with other treat-
ments. At 28 dpv and 35 dpv hematocrit levels de-
creased but treatment B was the highest and signifi-
cantly different with other treatments (P<0.05).
Hematocrit is the percentage ratio between the
solid red blood cells and plasma in the blood. Gene-
rally hematocrit before vaccination and one week af-
ter vaccination tend to be low and stable (Figure 2).
Entering the second week (14 dpv) hematocrit of treat-
ment A and B slightly higher and significantly
different (P<0.05) with the control and C. While the
hematocrit reached the highest peak in the third week
(21 dpv) is achieved by B. In normal conditions, he-
matocrit levels of carp ranged from 32% to 43.8% (Radu,
2009). Shortly after the challenge test, hematocrit
levels increased and then begin to decline until the
end of the maintenance period. Decrease in hema-
tocrit levels after challenge test showed that KHV
infection that attacks fish is quite serious. Factors
Figure 2. Hematocrit levels during the study period of adjuvant and for-
malin inactivated vaccine against KHV in koi. Description: no
vaccined, challanged (K+), no vaccined, no challanged (K-), vac-
cines (A), Complete Freund’s Adjuvant vaccined (B), Incomplete
Freund’s Adjuvant vaccined (C), vaccination (V), challenge test
(T). Different superscript in the same group time indicate sig-
nificantly different (P<0.05). Data are expressed as Mean ± SD
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causing the decrease in hematocrit allegedly associ-
ated with a decrease in hemoglobin due KHV infec-
tion. This decrease was associated with hemorrhage
in the base of the fin and bleeding in the brain.
Lysozyme Activity
Figure 3 shows lysozyme activity of fish. Before
vaccination, the amount of lysozyme activity was not
significantly different among treatments (P>0.05).
Lysozyme value of K+ and K- is significantly different
(P<0.05) with A and C and also significantly different
with the treatment B on the 7 dpv. At 14 dpv treat-
ment K+ and K- significantly different compared 21
dpv the activity of lysozyme reached the highest peak
in treatment B and significantly different from other
treatments. A week after the challenge test (28 dpv)
each lysozyme activity decreased and continue to
decrease till 35 dpv. Treatment B still shows higher
but not significantly different with treatment A
(P>0.05) and significantly different (P<0.05) with K+,
K-, and C.
Lysozyme is an important component in the de-
fence system against pathogens. Lysozyme in fish can
be detected from the serum, mucus, plasma, and
organs such as gills and liver. Figure 3 shows the
activity of lysozyme in general tends to increase   after
vaccination and tends to decrease after challenge test.
Vaccination treatment can increase the activity of
lysozyme and significantly different (P<0.05) with the
controls. Increased activity of this enzyme is also
obtained in tilapia injected ECP Pseudomonas fluorescens
(Attia et al., 2012). According Saurabh & Sahoo (2008)
lysozyme is a distributed hydrolase, and plays an im-
portant role in the biological defense system. This
enzyme has antiviral, antibacterial and anti-inflamma-
tory properties. In addition, increase lysozyme
activity closely associated with humoral factors that
can increase phagocytic activity in fish (Veersamy et
al., 2014).
On the positive control (K+) is very clearly
visible decrease in the activity of lysozyme after chal-
lenge test. Lysozyme in fish is an indicator of non-
specific immune response to the invasion of anti-
gens. Lysozyme is the first layer of defense mecha-
nism that is very important for fish to fight patho-
gens (Saurabh & Sahoo, 2008). Lysozyme can increase
phagocytic activity is as opsonin or directly activate
neutrophils and macrophages (Bhagwat et al., 2010).
Figure 3. The activity of lysozyme during the study period of adjuvant and
formalin inactivated vaccine against KHV in koi. Description: no
vaccined, challanged (K+), no vaccined, no challanged (K-), vac-
cines (A), Complete Freund’s Adjuvant vaccined (B) + Incomplete
Freund’s Adjuvant vaccined (C), vaccination (V), challenge test
(T). Different superscript in the same group time indicate sig-
nificantly different (P<0.05). Data are expressed as Mean ± SD
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CONCLUSION
The application of inactivated vaccine with the
addition of Complete Freund’s Adjuvant resulted the
highest survival and enhancement of the immune
response in koi (C. carpio) against KHV infection.
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